Andy Roddick defends Serena Williams' GLP-1 weight loss amid comeback talk

Former tennis star Andy Roddick has voiced support for Serena Williams' use of GLP-1 medication in her weight-loss efforts, suggesting it could aid a potential return to the court. Williams has shared how the treatment improved her health, while speculation grows following her inclusion in the anti-doping pool and practice sessions with younger players. Roddick emphasized the benefits for injury prevention during training.

In a recent episode of the Served podcast, Andy Roddick addressed criticism of Serena Williams' use of GLP-1 medication for weight loss. He stated that if he were attempting a comeback, he would prioritize rapid weight reduction to facilitate safer training. "I can tell you something that I think I know for a fact, right? I’m not Serena. I can’t play anymore. I stink. And if I decided that I wanted to come back, guess what I would be doing immediately? Immediately, I’d be dropping 20 pounds as fast as I can," Roddick said.

Roddick argued that starting lighter reduces injury risks during preparation, which is a major hurdle for returning athletes. "I would be taking those drugs because you know what becomes easier when you are 20 pounds lighter? Actually, getting back to the training that you need without getting injured to get back on tour," he explained. He added, "What it does is shortens the timeline for training and mitigates a lot of the risk in because the thing with getting back is like you get injured training, injured training, injured training, you can’t get back. Right."

Williams first discussed her use of the medication in an August 2025 interview with People Magazine and reinforced it in a Super Bowl XL advertisement in 2026. In a January 2026 interview with Today.com, she highlighted health improvements: "My blood sugar is better. I was able to lower my cholesterol by 30%. Some of these numbers [previous high cholesterol levels] are from when I was literally winning Grand Slams. It wasn’t, like, just playing tennis. I was dominating. I was at risk for heart disease, and I didn’t even know. … That’s scary."

Comeback rumors intensified after Williams' name appeared in the tennis anti-doping testing pool, a step often required for returning players. On the Today show in January 2026, she responded ambiguously: "I’m just having fun and enjoying my life right now," adding, "I don’t know, I’m just going to see what happens."

American player Alycia Parks recently practiced with Williams and commented on her fitness. "I actually practiced with her last Monday. And I messaged her yesterday. She’s definitely a good mentor to me, and she’s helped me a lot, especially in my practices," Parks told Tennis Majors. She added, "She is in great shape. So I think she would kill it on tour."

Support for Williams continues to build in the tennis community as discussions of a potential return, possibly emulating sister Venus, persist.

Articoli correlati

Serena Williams, fit and transformed, poses athletically with tennis racket against Super Bowl ad for Zepbound weight loss drug.
Immagine generata dall'IA

Serena Williams appears in Super Bowl ad for weight loss medication

Riportato dall'IA Immagine generata dall'IA

Serena Williams is set to feature in a Super Bowl commercial promoting the telehealth firm Ro and its GLP-1 weight loss medication Zepbound. The 44-year-old tennis legend discusses her body transformation, having lost up to 15.4kg since starting the treatment. The ad comes amid ongoing speculation about a potential return to professional tennis.

Alycia Parks, after her first-round win at the Miami Open, provided insights into Serena Williams' current tennis form from their practice sessions. The world No. 105 described Williams as fit and hitting well, though she remains uncertain about any professional comeback. Parks credits the sessions for boosting her own game.

Riportato dall'IA

The International Tennis Integrity Agency has officially reinstated Serena Williams as an active player, removing her from the retired list on February 22, 2026. This move follows her rejoining the anti-doping testing pool last year, making her eligible for tournaments. Her former coach Rick Macci expressed certainty about a comeback, citing her intensive training.

Britain's top padel player Aimee Gibson has pledged to return stronger following a torn calf muscle that sidelined her during a tournament in Bahrain. The 34-year-old, who had been climbing the world rankings, is now focusing on rehabilitation ahead of a potential comeback in May. She credits the setback with renewing her appreciation for the sport.

Riportato dall'IA

Three Cochrane reviews commissioned by the World Health Organization evaluate GLP-1 receptor agonists like tirzepatide, semaglutide, and liraglutide for weight loss in people with obesity. The drugs show substantial weight reduction compared to placebo, but researchers note limitations in long-term data and industry funding influences. Side effects such as nausea are common, raising questions about broader access and safety.

Top tennis players Carlos Alcaraz, Jannik Sinner and Aryna Sabalenka were instructed to remove their Whoop fitness trackers during the 2026 Australian Open. The devices, approved for ATP and WTA tours, remain banned at Grand Slams amid ongoing debates over player welfare and data rules. Tournament organizers are in discussions to potentially allow them in the future.

Riportato dall'IA

Retired tennis player Eugenie Bouchard has discussed the upheaval in her life following her 2014 Wimbledon final appearance, which brought sudden fame and high expectations. She described a rebellious phase that included a drastic hairstyle change, leading to the loss of a sponsorship deal. Now focused on pickleball, Bouchard emphasizes the complexity beyond her public image.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta